Literature DB >> 29598922

Diagnosis and assessment of neuropathic pain through questionnaires.

Nadine Attal1, Didier Bouhassira2, Ralf Baron3.   

Abstract

Neuropathic pain-pain caused by a lesion or disease of the somatosensory nervous system-is underdiagnosed and difficult to treat. However, development of easy-to-use questionnaires based mainly on self-reports of symptoms has improved diagnosis and management. Two types of questionnaires (screening and assessment) have been validated, and rapidly translated and revalidated in several languages, probably because of their simplicity. Screening questionnaires help clinicians to identify neuropathic pain easily, particularly in patients with complex medical conditions (eg, spinal cord injury). Their use in large-scale epidemiological studies has provided estimates of the prevalence of neuropathic pain and identified risk factors for neuropathic pain in the general population and in disorders such as diabetes. Assessment questionnaires measure neuropathic symptoms and have been used to create phenotypic profiles of patients in various neuropathic conditions. These profiles can predict treatment outcomes, and thus enable a personalised therapeutic approach. The dissemination of these questionnaires in different countries should further improve diagnosis and management worldwide and advance knowledge on the mechanisms of neuropathic pain.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29598922     DOI: 10.1016/S1474-4422(18)30071-1

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  32 in total

Review 1.  [Rheumatic diseases and neuropathic pain : Diagnosis and treatment].

Authors:  J Lassen; R Baron
Journal:  Z Rheumatol       Date:  2020-12-23       Impact factor: 1.372

Review 2.  [Diagnostics and therapy of neuropathic pain].

Authors:  G Gossrau; R Sabatowski
Journal:  Anaesthesist       Date:  2021-10-21       Impact factor: 1.041

Review 3.  Central Neuropathic Pain Syndromes: Current and Emerging Pharmacological Strategies.

Authors:  Katharine N Gurba; Rida Chaudhry; Simon Haroutounian
Journal:  CNS Drugs       Date:  2022-05-05       Impact factor: 6.497

4.  The Burden of Cancer-related Neuropathic Pain: A Multi-centric Cross-sectional Observational Study from North India.

Authors:  Aanchal Satija; Anjum Khan Joad; Shiv Pratap Singh Rana; Sushma Bhatnagar
Journal:  Indian J Palliat Care       Date:  2021-02-17

5.  Orofacial pain in 1916 patients with early or moderate Parkinson disease.

Authors:  Francis O'Neill; Christopher Kobylecki; Roberto Carrasco; Michele T Hu; Donald Grosset; Monty Silverdale
Journal:  Pain Rep       Date:  2021-04-13

Review 6.  Using stratified medicine to understand, diagnose, and treat neuropathic pain.

Authors:  Andreas C Themistocleous; Geert Crombez; Georgios Baskozos; David L Bennett
Journal:  Pain       Date:  2018-09       Impact factor: 7.926

7.  An International Survey on Temporomandibular Joint Surgeon's Implementation and Management of Discectomy in Treating Temporomandibular Joint Internal Derangement.

Authors:  Douglas F Werkman; Louis G Mercuri; Jonathan P Troost; Sharon Aronovich
Journal:  J Oral Maxillofac Surg       Date:  2021-01-08       Impact factor: 2.136

8.  Prolonged Use of NMDAR Antagonist Develops Analgesic Tolerance in Neuropathic Pain via Nitric Oxide Reduction-Induced GABAergic Disinhibition.

Authors:  Jun Li; Lin Zhang; Chu Xu; Yu-Hui Lin; Yu Zhang; Hai-Yin Wu; Lei Chang; Ying-Dong Zhang; Chun-Xia Luo; Fei Li; Dong-Ya Zhu
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

9.  Pharmacokinetic Modeling of the Impact of P-glycoprotein on Ondansetron Disposition in the Central Nervous System.

Authors:  Manting Chiang; Hyun-Moon Back; Jong Bong Lee; Sarah Oh; Tiffany Guo; Simone Girgis; Celine Park; Simon Haroutounian; Leonid Kagan
Journal:  Pharm Res       Date:  2020-09-28       Impact factor: 4.200

10.  A machine-vision approach for automated pain measurement at millisecond timescales.

Authors:  Jessica M Jones; William Foster; Colin R Twomey; Justin Burdge; Osama M Ahmed; Talmo D Pereira; Jessica A Wojick; Gregory Corder; Joshua B Plotkin; Ishmail Abdus-Saboor
Journal:  Elife       Date:  2020-08-06       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.